Immune monitoring in cancer vaccine clinical trials: Critical issues of functional flow cytometry-based assays

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Macchia, Iole ^a   Urbani, Francesca ^a   Proietti, Enrico ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CANCER ANTIBODY; CD8 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MELAN A; MELANOMA VACCINE; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CANCER VACCINE; TUMOR MARKER;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN SPECIFICITY; CANCER CONTROL; CANCER IMMUNIZATION; CANCER PATIENT; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MARKER; DRUG RESEARCH; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVIEW; T CELL CULTURE; ANIMAL; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; FLOW CYTOMETRY; HUMANS; MELANOMA; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 84886563697     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/726239     Document Type: Review

References (70)

1. Whiteside T. L., Immune responses to cancer: are they potential biomarkers of prognosis? Frontiers in Oncology 2013 3, article 107 10.3389/fonc.2013.00107
2. Vergati M., Intrivici C., Huen N.-Y., Schlom J., Tsang K. Y., Strategies for cancer vaccine development. Journal of Biomedicine and Biotechnology 2010 2010 13 2-s2.0-77955375829 10.1155/2010/596432 596432
3. Dobrzanski M. J., Expanding roles for CD4 T-cells and their subpopulations in tumor immunity and therapy. Frontiers in Oncology 2013 3, article 63 10.3389/fonc.2013.00063
4. Vergati M., Schlom J., Tsang K. Y., The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. Journal of Biomedicine and Biotechnology 2011 2011 8 2-s2.0-79952215950 10.1155/2011/182413 182413
5. Olson B. M., McNeel D. G., Monitoring regulatory immune responses in tumor immunotherapy clinical trials. Frontiers in Oncology 2013 3, article 109
6. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V., Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunological Reviews 2008 222 1 162 179 2-s2.0-41149119143 10.1111/j.1600-065X.2008.00602.x (Pubitemid 351430364)
7. Biragyn A., Lee-Chang C., A new paradigm for an old story: the role of regulatory B cells in cancer. Frontiers in Immunology 2012 3, article 206
8. Tjin E. P. M., Konijnenberg D., Krebbers G., Mallo H., Drijfhout J. W., Franken K. L. M. C., van der Horst C. M. A. M., Bos J. D., Nieweg O. E., Kroon B. B. R., Haanen J. B. A. G., Melief C. J. M., Vyth-Dreese F. A., Luiten R. M., T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clinical Cancer Research 2011 17 17 5736 5747 2-s2.0-80052432557 10.1158/1078-0432.CCR-11-0230
9. Galon J., Pagès F., Marincola F. M., Thurin M., Trinchieri G., Fox B. A., Gajewski T. F., Ascierto P. A., The immune score as a new possible approach for the classification of cancer. Journal of Translational Medicine 2012 10, article 1 2-s2.0-84855225492 10.1186/1479-5876-10-1
10. Galon J., Pag ès F., Marincola F. M., Cancer classification using the Immunoscore: a worldwide task force. Journal of Translational Medicine 2012 10, article 205 10.1186/1479-5876-10-205
11. Sobin L. H., Compton C. C., TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010 116 22 5336 5339 2-s2.0-78449279894 10.1002/cncr.25537
12. Wittekind C., Compton C. C., Greene F. L., Sobin L. H., TNM residual tumor classification revisited. Cancer 2002 94 9 2511 2516 2-s2.0-0036569580 10.1002/cncr.10492 (Pubitemid 34457134)
13. Ascierto P. A., Capone M., Urba W. J., The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment. Journal of Translational Medicine 2013 11, article 54 10.1186/1479-5876-11-54
14. Fridman W. H., Pagès F., Sautès-Fridman C., Galon J., The immune contexture in human tumours: impact on clinical outcome. Nature Reviews Cancer 2012 12 4 298 306 2-s2.0-84858800620 10.1038/nrc3245
15. Pagès F., Kirilovsky A., Mlecnik B., In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. Journal of Clinical Oncology 2009 27 35 5944 5951 10.1200/JCO.2008.19.6147
16. Olson W. C., Smolkin M. E., Farris E. M., Fink R. J., Czarkowski A. R., Fink J. H., Chianese-Bullock K. A., Slingluff C. L. Jr., Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function. Journal of Translational Medicine 2011 9, article 26 2-s2.0-79952320073 10.1186/1479-5876-9-26
17. Disis M. L., Dela Rosa C., Goodell V., Kuan L.-Y., Chang J. C. C., Kuus-Reichel K., Clay T. M., Kim Lyerly H., Bhatia S., Ghanekar S. A., Maino V. C., Maecker H. T., Maximizing the retention of antigen specific lymphocyte function after cryopreservation. Journal of Immunological Methods 2006 308 1-2 13 18 2-s2.0-30844465227 10.1016/j.jim.2005.09.011 (Pubitemid 43107950)
18. Maecker H. T., Moon J., Bhatia S., Ghanekar S. A., Maino V. C., Payne J. K., Kuus-Reichel K., Chang J. C., Summers A., Clay T. M., Morse M. A., Lyerly H. K., DeLaRosa C., Ankerst D. P., Disis M. L., Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunology 2005 6, article 17 2-s2.0-26444449604 10.1186/1471-2172-6-17 (Pubitemid 41418107)
19. Weinberg A., Song L.-Y., Wilkening C., Sevin A., Blais B., Louzao R., Stein D., Defechereux P., Durand D., Riedel E., Raftery N., Jesser R., Brown B., Keller M. F., Dickover R., McFarland E., Fenton T., Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clinical and Vaccine Immunology 2009 16 8 1176 1186 2-s2.0-68149137514 10.1128/CVI.00342-08
20. McLaughlin B. E., Baumgarth N., Bigos M., Roederer M., De Rosa S. C., Altman J. D., Nixon D. F., Ottinger J., Oxford C., Evans T. G., Asmuth D. M., Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: panel design by an empiric approach. Cytometry A 2008 73 5 400 410 2-s2.0-42949147530 10.1002/cyto.a.20555 (Pubitemid 351614727)
21. Papagno L., Almeida J. R., Nemes E., Autran B., Appay V., Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity. Journal of Immunological Methods 2007 328 1-2 182 188 2-s2.0-35548929000 10.1016/j.jim.2007.09.001 (Pubitemid 350017756)
22. Maecker H. T., Trotter J., Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 2006 69 9 1037 1042 2-s2.0-33749497954 10.1002/cyto.a.20333 (Pubitemid 44521985)
23. Kalina T., Flores-Montero J., van der Velden V. H., Euroflow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012 26 9 1986 2010 10.1038/leu.2012.122
24. De Rosa S. C., Carter D. K., McElrath M. J., OMIP-014: validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining. Cytometry A 2012 81 12 1019 1021 10.1002/cyto.a.22218
25. Makedonas G., Betts M. R., Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Seminars in Immunopathology 2006 28 3 209 219 2-s2.0-33751071052 10.1007/s00281-006-0025-4 (Pubitemid 44764277)
26. Betts M. R., Nason M. C., West S. M., De Rosa S. C., Migueles S. A., Abraham J., Lederman M. M., Benito J. M., Goepfert P. A., Connors M., Roederer M., Koup R. A., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006 107 12 4781 4789 2-s2.0-33646686040 10.1182/blood-2005-12-4818 (Pubitemid 43882629)
27. + T cell responses. Journal of Experimental Medicine 2007 204 6 1405 1416 2-s2.0-34250327922 10.1084/jem.20062363 (Pubitemid 46919878)
28. Yuan J., Gnjatic S., Li H., Powel S., Gallardo H. F., Ritter E., Ku G. Y., Jungbluth A. A., Segal N. H., Rasalan T. S., Manukian G., Xu Y., Roman R.-A., Terzulli S. L., Heywood M., Pogoriler E., Ritter G., Old L. J., Allison J. P., Wolchok J. D., CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proceedings of the National Academy of Sciences of the United States of America 2008 105 51 20410 20415 2-s2.0-58149483422 10.1073/pnas.0810114105
29. + T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition. Journal of Immunology 2012 189 2 598 605 10.4049/jimmunol.1102165
30. de Rosa S. C., Vaccine applications of flow cytometry. Methods 2012 57 3 383 391 2-s2.0-84856345164 10.1016/j.ymeth.2012.01.001
31. Clay T. M., Hobeika A. C., Mosca P. J., Lyerly H. K., Morse M. A., Assays for monitoring cellular immune responses to active immunotherapy of cancer. Clinical Cancer Research 2001 7 5 1127 1135 2-s2.0-0034901519 (Pubitemid 32708661)
32. Keilholz U., Martus P., Scheibenbogen C., Immune monitoring of T-cell responses in cancer vaccine development. Clinical Cancer Research 2006 12 7, part 2 2346s 2352s 2-s2.0-33646236935 10.1158/1078-0432.CCR-05-2540
33. + T cells. European Journal of Immunology 2009 39 1 241 253 2-s2.0-60549109302 10.1002/eji.200838824
34. Horton H., Thomas E. P., Stucky J. A., Frank I., Moodie Z., Huang Y., Chiu Y.-L., McElrath M. J., De Rosa S. C., Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. Journal of Immunological Methods 2007 323 1 39 54 2-s2.0-34248149301 10.1016/j.jim.2007.03.002 (Pubitemid 46722712)
35. + T cells by a flow cytometric assay for degranulation. Journal of Immunological Methods 2003 281 1-2 65 78 2-s2.0-0142185336 10.1016/S0022-1759(03)00265-5 (Pubitemid 37324571)
36. Rubio V., Stuge T. B., Singh N., Betts M. R., Weber J. S., Roederer M., Lee P. P., Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nature Medicine 2003 9 11 1377 1382 2-s2.0-0345276633 10.1038/nm942 (Pubitemid 37466186)
37. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996 274 5284 94 96 2-s2.0-0029743737 10.1126/science.274.5284.94 (Pubitemid 26332731)
38. Yee C., Greenberg P., Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nature Reviews Cancer 2002 2 6 409 419 2-s2.0-0036593490 (Pubitemid 37328938)
39. Klenerman P., Cerundolo V., Dunbar P. R., Tracking T cells with tetramers: new tales from new tools. Nature Reviews Immunology 2002 2 4 263 272 2-s2.0-0036549509 (Pubitemid 37323226)
40. + T cell responses using MHC/peptide tetramers in cancer patients. International Immunopharmacology 2001 1 7 1235 1247 2-s2.0-0035021010 10.1016/S1567-5769(01)00048-0 (Pubitemid 32522978)
41. Guillaume P., Dojcinovic D., Luescher I. F., Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. Cancer Immunity 2009 9, article 7 2-s2.0-74749107592
42. Singh S. K., Tummers B., Schumacher T. N., The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study. Cancer Immunology, Immunotherapy 2013 62 3 489 501 10.1007/s00262-012-1351-0
43. Fox B. A., Schendel D. J., Butterfield L. H., Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine 2011 9, article 214 10.1186/1479-5876-9-214
44. van der Burg S. H., Kalos M., Gouttefangeas C., Harmonization of immune biomarker assays for clinical studies. Science translational medicine 2011 3 108 108ps44 10.1126/scitranslmed.3002785
45. O'Donnell E. A., Ernst D. N., Hingorani R., Multiparameter flow cytometry: advances in high resolution analysis. Immune Network 2013 13 2 43 54
46. Janetzki S., Britten C. M., Kalos M., Levitsky H. I., Maecker H. T., Melief C. J. M., Old L. J., Romero P., Hoos A., Davis M. M., "MIATA"-minimal information about T cell assays. Immunity 2009 31 4 527 528 2-s2.0-70349833381 10.1016/j.immuni.2009.09.007
47. Moodie Z., Price L., Janetzki S., Britten C. M., Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. Methods in Molecular Biology 2012 792 185 196 2-s2.0-80555129210 10.1007/978-1-61779-325-7-15
48. Britten C. M., Janetzki S., Ben-Porat L., Clay T. M., Kalos M., Maecker H., Odunsi K., Pride M., Old L., Hoos A., Romero P., Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the cancer vaccine consortium. Cancer Immunology, Immunotherapy 2009 58 10 1701 1713 2-s2.0-68549133403 10.1007/s00262-009-0681-z
49. Welters M. J., Gouttefangeas C., Ramwadhdoebe T. H., Harmonization of the intracellular cytokine staining assay. Cancer Immunology, Immunotherapy 2012 61 7 967 978 10.1007/s00262-012-1282-9
50. Maecker H. T., McCoy J. P., Corrigendum: a model for harmonizing flow cytometry in clinical trials. Nature Immunology 2011 12 271 975 978 2-s2.0-79951600488 10.1038/ni0311-271d
51. Maecker H. T., Rinfret A., D'Souza P., Standardization of cytokine flow cytometry assays. BMC Immunology 2005 6, article 13 10.1186/1471-2172-6-13 (Pubitemid 41418111)
52. Nomura L., Maino V. C., Maecker H. T., Standardization and optimization of multiparameter intracellular cytokine staining. Cytometry A 2008 73 11 984 991 2-s2.0-55949121648 10.1002/cyto.a.20602
53. Pierzchalski A., Mittag A., Tárnok A., Introduction A: recent advances in cytometry instrumentation, probes, and methods-review. Methods in Cell Biology 2011 102 1 21 2-s2.0-79959580038 10.1016/B978-0-12-374912-3.00001-8
54. Baumgaertner P., Jandus C., Rivals J.-P., Derré L., Lövgren T., Baitsch L., Guillaume P., Luescher I. F., Berthod G., Matter M., Rufer N., Michielin O., Speiser D. E., Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells. International Journal of Cancer 2012 130 11 2607 2617 2-s2.0-84859160195 10.1002/ijc.26297
55. Lin Y., Gallardo H. F., Ku G. Y., Li H., Manukian G., Rasalan T. S., Xu Y., Terzulli S. L., Old L. J., Allison J. P., Houghton A. N., Wolchok J. D., Yuan J., Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy 2009 11 7 912 922 2-s2.0-70450180833 10.3109/ 14653240903136987
56. Lamoreaux L., Roederer M., Koup R., Intracellular cytokine optimization and standard operating procedure. Nature Protocols 2006 1 3 1507 1516 2-s2.0-34347232370 10.1038/nprot.2006.268
57. + T cells. Journal of Immunological Methods 2006 310 1-2 136 148 2-s2.0-33644870586 10.1016/j.jim.2006.01.006 (Pubitemid 43375983)
58. Roederer M., Nozzi J. L., Nason M. C., SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011 79 2 167 174 2-s2.0-79251515158 10.1002/cyto.a.21015
59. Duvall M. G., Precopio M. L., Ambrozak D. A., Polyfunctional T cell responses are a hallmark of HIV-2 infection. European Journal of Immunology 2008 38 2 350 363 10.1002/eji.200737768
60. Bendall S. C., Nolan G. P., Roederersend M., Chattopadhyay P. K., A deep profiler's guide to cytometry. Trends in Immunology 2012 33 7 323 332 10.1016/j.it.2012.02.010
61. Hahne F., LeMeur N., Brinkman R. R., Ellis B., Haaland P., Sarkar D., Spidlen J., Strain E., Gentleman R., flowcore: a bioconductor package for high throughput flow cytometry. BMC Bioinformatics 2009 10, article 106 2-s2.0-65949097067 10.1186/1471-2105-10-106
62. Roederer M., Moore W., Treister A., Hardy R. R., Herzenberg L. A., Probability binning comparison: a metric for quantitating multivariate distribution differences. Cytometry 2001 45 1 47 55 bb (Pubitemid 32807923)
63. Kalina T., Stuchlý J., Janda A., Hrušák O., Růžičková Š., Šedivá A., Litzman J., Vlková M., Profiling of polychromatic flow cytometry data on B-cells reveals patients' clusters in common variable immunodeficiency. Cytometry A 2009 75 11 902 909 2-s2.0-71049151682 10.1002/cyto.a.20801
64. Qiu P., Inferring phenotypic properties from single-cell characteristics. PLoS One 2012 7 5 e37038
65. Qiu P., Simonds E. F., Bendall S. C., Gibbs K. D., Bruggner R. V., Linderman M. D., Sachs K., Nolan G. P., Plevritis S. K., Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nature Biotechnology 2011 29 10 886 891 2-s2.0-80054768631 10.1038/nbt.1991
66. Frelinger J., Ottinger J., Gouttefangeas C., Chan C., Modeling flow cytometry data for cancer vaccine immune monitoring. Cancer Immunology, Immunotherapy 2010 59 9 1435 1441 2-s2.0-77955512886 10.1007/s00262-010-0883-4
67. Simon S., Guthke R., Kamradt T., Frey O., Multivariate analysis of flow cytometric data using decision trees. Frontiers in Microbiology 2012 3, article 114 10.3389/fmicb.2012.00114
68. Janetzki S., Panageas K. S., Ben-Porat L., Boyer J., Britten C. M., Clay T. M., Kalos M., Maecker H. T., Romero P., Yuan J., Martin Kast W., Hoos A., Results and harmonization guidelines from two large-scale international elispot proficiency panels conducted by the cancer vaccine consortium (CVC/SVI). Cancer Immunology, Immunotherapy 2008 57 3 303 315 2-s2.0-37349020262 10.1007/s00262-007-0380-6 (Pubitemid 350295382)
69. De Rosa S. C., Lu F. X., Yu J., Perfetto S. P., Falloon J., Moser S., Evans T. G., Koup R., Miller C. J., Roederer M., Vaccination in humans generates broad T cell cytokine responses. Journal of Immunology 2004 173 9 5372 5380 2-s2.0-6344269428 (Pubitemid 39392120)
70. Butterfield L. H., Palucka A. K., Britten C. M., Dhodapkar M. V., Håkansson L., Janetzki S., Kawakami Y., Kleen T.-O., Lee P. P., Maccalli C., Maecker H. T., Maino V. C., Maio M., Malyguine A., Masucci G., Pawelec G., Potter D. M., Rivoltini L., Salazar L. G., Schendel D. J., Slingluff C. L. Jr., Song W., Stroncek D. F., Tahara H., Thurin M., Trinchieri G., Van Der Burg S. H., Whiteside T. L., Wigginton J. M., Marincola F., Khleif S., Fox B. A., Disis M. L., Recommendations from the iSBTc-SITC/FDA/NCI workshop on immunotherapy biomarkers. Clinical Cancer Research 2011 17 10 3064 3076 2-s2.0-79956000143 10.1158/1078-0432.CCR-10-2234